AAAAAA

   
Results: 1-12 |
Results: 12
PREDICTING HEMATOLOGICAL TOXICITY (MYELOSUPPRESSION) OF CYTOTOXIC DRUG-THERAPY FROM IN-VITRO TESTS
Authors: PARCHMENT RE GORDON M GRIESHABER CK SESSA C VOLPE D GHIELMINI M
Citation: Re. Parchment et al., PREDICTING HEMATOLOGICAL TOXICITY (MYELOSUPPRESSION) OF CYTOTOXIC DRUG-THERAPY FROM IN-VITRO TESTS, Annals of oncology, 9(4), 1998, pp. 357-364
IN-VITRO HEMATOTOXICOLOGY STUDIES OF NEUTROPENIA INDUCED BY THE NOVELAGENT XK469
Authors: PARCHMENT RE TOMASZEWSKI JE GRIESHABER CK VALERIOTE FA CORBETT TH LORUSSO PM
Citation: Re. Parchment et al., IN-VITRO HEMATOTOXICOLOGY STUDIES OF NEUTROPENIA INDUCED BY THE NOVELAGENT XK469, Annals of oncology, 9, 1998, pp. 205-205
PHASE-I CLINICAL-TRIAL OF KRN5500
Authors: LORUSSO PM FOSTER B WOZNIAK A FLAHERTY L SHIELDS A ZALUPSKI M KOCAREK T GRIESHABER CK PARCHMENT RE
Citation: Pm. Lorusso et al., PHASE-I CLINICAL-TRIAL OF KRN5500, Annals of oncology, 9, 1998, pp. 474-474
ALTERNATIVE TESTING SYSTEMS FOR EVALUATING NONCARCINOGENIC, HEMATOLOGIC TOXICITY
Authors: PARCHMENT RE
Citation: Re. Parchment, ALTERNATIVE TESTING SYSTEMS FOR EVALUATING NONCARCINOGENIC, HEMATOLOGIC TOXICITY, Environmental health perspectives, 106, 1998, pp. 541-557
HAEMATOTOXICITY OF MYCOTOXINS
Authors: PARENTMASSIN D PARCHMENT RE
Citation: D. Parentmassin et Re. Parchment, HAEMATOTOXICITY OF MYCOTOXINS, Revue de Medecine Veterinaire, 149(6), 1998, pp. 591-598
DIFFERENTIAL TOXICITY OF CAMPTOTHECIN, TOPOTECAN AND 9-AMINOCAMPTOTHECIN TO HUMAN, CANINE, AND MURINE MYELOID PROGENITORS (CFU-GM) IN-VITRO
Authors: ERICKSONMILLER CL MAY RD TOMASZEWSKI J OSBORN B MURPHY MJ PAGE JG PARCHMENT RE
Citation: Cl. Ericksonmiller et al., DIFFERENTIAL TOXICITY OF CAMPTOTHECIN, TOPOTECAN AND 9-AMINOCAMPTOTHECIN TO HUMAN, CANINE, AND MURINE MYELOID PROGENITORS (CFU-GM) IN-VITRO, Cancer chemotherapy and pharmacology, 39(5), 1997, pp. 467-472
MYELOTOXIC EFFECTS OF THE BIFUNCTIONAL ALKYLATING AGENT BIZELESIN ON HUMAN, CANINE AND MURINE MYELOID PROGENITOR CELLS
Authors: VOLPE DA TOMASZEWSKI JE PARCHMENT RE GARG A FLORA KP MURPHY MJ GRIESHABER CK
Citation: Da. Volpe et al., MYELOTOXIC EFFECTS OF THE BIFUNCTIONAL ALKYLATING AGENT BIZELESIN ON HUMAN, CANINE AND MURINE MYELOID PROGENITOR CELLS, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 143-149
STAGE-DEPENDENT GENETICALLY-BASED DEFORMITIES OF THE REGENERATING NEWT LIMB FROM 4-NITROQUINOLINE-N-OXIDE MUTAGENESIS - POTENTIAL EMBRYONICREGULATION OF CANCER
Authors: ZILAKOS NP ZAFIRATOS CS PARCHMENT RE
Citation: Np. Zilakos et al., STAGE-DEPENDENT GENETICALLY-BASED DEFORMITIES OF THE REGENERATING NEWT LIMB FROM 4-NITROQUINOLINE-N-OXIDE MUTAGENESIS - POTENTIAL EMBRYONICREGULATION OF CANCER, Differentiation, 60(2), 1996, pp. 67-74
AUTOMATED IMAGING AND QUANTITATION OF TUMOR-CELLS AND CFU-GM COLONIESIN MICROCAPILLARY CULTURES - TOWARD THERAPEUTIC INDEX-BASED DRUG SCREENING
Authors: MURPHY MJ FUSHIMI F PARCHMENT RE BARBERAGUILLEM E
Citation: Mj. Murphy et al., AUTOMATED IMAGING AND QUANTITATION OF TUMOR-CELLS AND CFU-GM COLONIESIN MICROCAPILLARY CULTURES - TOWARD THERAPEUTIC INDEX-BASED DRUG SCREENING, Investigational new drugs, 13(4), 1995, pp. 303-314
IN-VIVO-IN-VITRO CORRELATION OF MYELOTOXICITY OF 9-METHOXYPYRAZOLOACRIDINE (NSC-366140, PD115934) TO MYELOID AND ERYTHROID HEMATOPOIETIC PROGENITORS FROM HUMAN, MURINE, AND CANINE MARROW
Authors: PARCHMENT RE VOLPE DA LORUSSO PM ERICKSONMILLER CL MURPHY MJ GRIESHABER CK
Citation: Re. Parchment et al., IN-VIVO-IN-VITRO CORRELATION OF MYELOTOXICITY OF 9-METHOXYPYRAZOLOACRIDINE (NSC-366140, PD115934) TO MYELOID AND ERYTHROID HEMATOPOIETIC PROGENITORS FROM HUMAN, MURINE, AND CANINE MARROW, Journal of the National Cancer Institute, 86(4), 1994, pp. 273-280
ROLES FOR IN-VITRO MYELOTOXICITY TESTS IN PRECLINICAL DRUG DEVELOPMENT AND CLINICAL-TRIAL PLANNING
Authors: PARCHMENT RE HUANG M ERICKSONMILLER CL
Citation: Re. Parchment et al., ROLES FOR IN-VITRO MYELOTOXICITY TESTS IN PRECLINICAL DRUG DEVELOPMENT AND CLINICAL-TRIAL PLANNING, Toxicologic pathology, 21(2), 1993, pp. 241-250
MEGAKARYOCYTE COLONY-STIMULATING FACTOR (MEG-CSF) IS A UNIQUE CYTOKINE SPECIFIC FOR THE MEGAKARYOCYTE LINEAGE
Authors: ERICKSONMILLER CL JI H PARCHMENT RE MURPHY MJ
Citation: Cl. Ericksonmiller et al., MEGAKARYOCYTE COLONY-STIMULATING FACTOR (MEG-CSF) IS A UNIQUE CYTOKINE SPECIFIC FOR THE MEGAKARYOCYTE LINEAGE, British Journal of Haematology, 84(2), 1993, pp. 197-203
Risultati: 1-12 |